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3IMM Project Goals
• To develop an integrated, quantified, 
evidence-based decision support tool 
useful to crew health and mission 
planners.
• To help align science, technology, and 
operational activities intended to 
optimize crew health, safety, and 
mission success.
4Scope and Approach
• Scope
• Forecast medical outcomes for in-flight operations only
• Forecast medical impacts to mission
• Does not assess long-term or chronic post-mission 
medical consequences
• Approach
• Use ISS data as stepping stone to Exploration Program
• Employ best-evidence clinical research methods
• Employ Probability Risk Assessment (PRA) techniques
• Collaborate with other NASA Centers and Organizations
IMM addresses in-flight risk using ISS data as a stepping stone
5What is IMM?
• A software-based decision support tool 
• Forecasts the impact of medical events on 
space flight missions
• Optimizes the medical system within the 
constraints of the space flight environment 
during simulations
6Who can benefit from IMM capabilities?
• Flight Surgeons
• What in-flight medical threats are greatest for reference mission A?
• Risk Managers
• What is the risk of evacuation - due to a medical event - for a 6-person, 
180-day mission assuming the current in-flight medical capability?
• Vehicle Designers
• What is the optimum medical mass allocation for given level of risk?
• Health Care System Designers
• What medical items do we fly for a given mass/volume allocation?
• Trainers
• How do I prioritize limited crew training hours?
• Requirement Managers
• What is the rationale for this crew health requirement?
7“What if…?” Questions
• Questions
• Is the current ISS medical kit adequate for a crew of 6 on a 
6-month mission?
• Does a 33-day lunar sortie mission require a different Level 
of Care than a 24-day lunar sortie mission?
• Are we carrying enough Ibuprofen for a crew of six on a 12-
month mission?
• How does risk change if the ventilator fails at the start of a 3-
year mission?
• Questions
• What is the probability of a bone fracture occurring 10-years 
after a 6-month mission?
• What is the probability of renal stone formation after a 12-
month mission?
IMM is designed to help answer specific in-flight questions
Use History
• ISS medical system redesign rationale
• Storage Capacity Requirements of Vomitus   
and Diarrhea for Constellation
• ExMC List of Prioritized Medical Conditions
• ExMC Technology Watch
• Orion medical kit design support
• ISS Probabilistic Risk Assessment Updates
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9Risk and Risk Components
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5 x 5 Risk Matrix
Threat A
RiskRisk
5x5 Matrix IMM
Likelihood 
(Score 1-5)
Medical 
Condition 
Incidence
Mitigation? In-flight Medical 
Capabilities
Outcome 
(Score 1-5)
Crew Functional 
Impairment
Risk Score (2x1) 
for a single “risk”
Impact to mission 
due to all medical 
conditions for the 
crew compliment
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“Risk” is what is left over after you have accounted for likelihood, 
outcome, and the mitigation associated with the threat. 
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IMM Conceptual Model
INPUTS
 Medical 
Conditions & 
Incidence Data
 Crew Profile
 Mission Profile & 
Constraints
 Potential Crew 
Impairments
 Potential Mission 
End states
 In-flight Medical 
Resources
Integrated
Medical
Model
OUTPUTS
 Medical Condition 
Occurrences
 Crew Impairments
 Clinical End States
 Mission End States
 Resource Utilization
 Optimized Medical 
System
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Comparison – 5x5 Risk Matrix vs. IMM
Integrated
Medical
Model
Medical Conditions & 
Incidence Data
Crew Profile
Mission Profile & Constraints
Crew Functional 
Impairments
 In-flight Medical Resources
Medical Condition Occurrences
Crew Impairment
Clinical/Mission End States
Resource Utilization
Optimization of Vehicle 
Constraints and Medical 
System Capabilities
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d Risk • Qualitative
• Categorical
• Subjective
• Single Risk
• No Uncertainty
• No Confidence Interval
• Limited context
• Quantitative
• Probabilistic, Stochastic
• Evidence-based
• Integrated Risks
• Uncertainty
• Confidence Interval
• In context
5x5 Matrix IMM
Risk
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IMM Logic - Event Sequence Diagram
Medical 
Event
Treated case: 
Decrement 
medical 
resources
Yes
Untreated   
Worst- Case
No
Untreated      
Best-Case
No
Worst-case 
resources 
available?
Worst-case Scenario
Best-case 
resources 
available?
Treated case: 
Decrement 
medical 
resources
Calculate End 
States:
•Risk of Evacuation
•Risk of Loss of Crew 
Life
•Crew Functional 
Impairment
•Resource Utilization 
and Depletion
•Type and Quantify of 
Medical  Events 
(organized by Medical, 
Injury, or 
Environmental 
categories)
Yes
Best-case Scenario
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IMM Logic
• Did the medical condition happen?
• How many times?
• Best or worst-case scenario?
• Were resources available?
• What was the outcome?
1
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For each comparative assessment, the identical questions 
are asked 10,000+ times to develop outcome distributions
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Key Development Steps
• Develop and Validate a Conceptual Model
• Create initial list of relevant medical conditions
• Characterize incidence data
• Quantify crew impairment and clinical end states
• Quantify resources needed to diagnose and treat
• Develop a quantified Crew Health Index
• Understand implications of assumptions
• Verify & Validate
• Refine & Maintain Data
Each step is  critical in the development process  
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IMM Clinical Inputs
• Medical Conditions
• Incidence Rates
• Functional Impairments
• Potential End States (EVAC, LOCL)
• Required Resources
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Medical Condition List
Purpose
• To provide a list of medical conditions relevant to in-flight 
operations
Relevant Medical Conditions
• Have occurred in flight or has the potential to occur in flight
• Require mitigation and/or result in functional impairment
Current Status
• Consists of 83 medical conditions (47 have occurred in flight)
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Longitudinal Study of Astronaut Health
In-flight Medical Condition Occurrences
• Includes Apollo, Skylab, Mir, Shuttle, and ISS
• STS-1 through STS-114 in 2005
• Expedition 1 through Expedition 13 in 2006
• 47 relevant medical conditions
IMM Evidence Base
• Longitudinal Study of Astronaut Health
• Review of crew medical debriefs
• Analog population data
• General terrestrial population data
• Flight Surgeon Delphi Study
Russian medical data not included
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The Use of Incidence
• Incidence is a measure of the likelihood of 
developing a medical condition
• IMM uses incidence to quantify the likelihood
of occurrence of medical conditions in flight
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Incidence Definitions
The number of new medical events that occur 
within a specified time period
Incidence Proportion (Cumulative Incidence)
• The proportion of a population who develop a medical condition 
within a specified period of time (events/person)
Incidence Rate (Incidence Density)
• The number of new medical events that occur within a 
population divided by the total time the population was at risk 
(events/person-year)
• Accounts for the different times that each individual was at risk
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IMM Classification of Medical Conditions
Space Adaptation Syndrome (SAS)
Non-Space Adaptation Syndrome
22
SAS Medical Conditions
1) Back Pain
2) Constipation
3) Headache 
4) Insomnia
5) Nasal Congestion
6) Nosebleed
7) Space Motion Sickness
8) Urinary Incontinence
9) Urinary Retention
23
Space Adaptation Syndrome Medical Conditions
• Likelihood of occurrence is not related to 
mission duration
• Condition does not recur
• Incidence proportions (events/person)     
are determined from LSAH in flight 
occurrence data
Example: Nasal Congestion
405 events among 660 persons = 0.614 events/person
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Non-SAS Medical Conditions
• The likelihood of occurrence is related to 
mission duration
• Condition may recur
• Incidence rates (events/person-year) are 
determined from LSAH in-flight occurrence 
data or other sources
Example: Skin Rash
90 events within 27.34 person-years = 3.29 events/person-year
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Non-Space Adaptation Syndrome Medical Conditions
Incidence Rate Determinations
Conditions that have occurred in flight
• LSAH in-flight occurrence data 
Conditions that have not occurred in flight
• External models (fractures)
• Environmental engineering data (altitude sickness)
• Terrestrial general/analog population data 
(appendicitis)
• Bayesian statistics for rare events (kidney stones)
Independent Risk Models & IMM
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Integrated
Medical
Model
Independent
Model 
(Renal Stone)
Independent
Model 
(Bone Fracture)
For a specified mission scenario, the 
output from independent models can 
provide distributions of incidence data.
Risk Drivers
Risk of EVAC
Risk of LOCL
t
Model 
(TBD)
Model 
(TBD)
Indep ndent
Model 
(Insomnia)
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The Use of Functional Impairments
IMM uses the concept of functional impairments to 
quantify the severity of medical condition outcomes
Outcome
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Impairment
• A loss or loss of use of a body part, 
organ system, or organ function
• Considers both anatomic and 
functional loss
• Can develop from an illness or injury
28
American Medical Association Guides to the 
Evaluation of Permanent Impairment
Impairments
• Percentages that reflect the severity of the medical condition
• No impairment = 0 percent
• Fully dependant/approaching death = 100 percent
Examples
Skin Infection = 10 to 24 percent impairment
Shoulder Dislocation = 36 to 74 percent impairment
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Clinical Findings Form (CliFF)
Standardized Format for IMM Clinical Inputs
The likelihood of occurrence of the medical condition
• Incidence proportion or incidence rate
The clinical outcomes of the medical condition
• Considers ISS-based best-case, worst-case, and untreated 
case scenarios
• Specifies functional impairments and duration times
• Specifies potential end states (evacuation, loss of crew life)
• Specifies levels of evidence for input data
• References sources of data
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Resource Tables
• Specifies resources required 
for diagnosis and treatment
• Considers the  best-case and 
worst-case scenarios
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The Resource Tables specify the required      
in-flight medical resources
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Best and Worst Cases
Consumable
Disorder: 
Musculoskeletal
Description Quantity
Power 
(W)
Cost 
Estimates
 COTS 
Flight 
Certify
Sustaining 
Eng
1
Sprain/Strain 
Extremities
Ace Bandage 1 0.03875 38.75 442.5 442500  $       3.08 
SAM splint 1 0.1134 113.4 1336.3575 1336357.5  $     12.00 
1 Acetaminophen 2 0.00036 0.36 0.02632 26.32  $       0.10 
1 Ibuprofen 1-9 0.00066 0.66 0.04202 42.02  $       0.14 
        Mass
   Kg           Gm
          Volume 
       cc3          mm3
Mass
Kg    M
Volume
c3              mm3
Consumable COTSQuantity
Consumable Disorder Description Quantity Power
Cost 
Estimates 
 COTS 
Flight 
Certify
Sustaining 
Eng
Sprain/Strain 
Extremities Ace Bandage 1 0.03875 38.75 442.5000 442500  $       3.08 
SAM splint 1 0.1134 113.4 1336.3575 1336357.5  $     12.00 
1
acetaminophen (2 tabs*4-
6hr) 8 0.00036 0.36 0.0263 26.32  $       0.10 
1 ibuprofen (1-2 tabs*8hr) 10 0.00066 0.66 0.0420 42.02  $       0.14 
1 Vicodin (1-2 tabs *4-6 hr) 2 0.00064 0.64 0.0483 48.30 0.50$        
1 Gauze Pads 4 0.00504 5.04 7.6000 7600.00 0.16$        
1 Nonsterile Gloves pr 1 0.014 14 3.1000 3100 0.10$        
Sharps container 1 0.59553 595.53 2909.1250 2909125.00 817.06$      
1 20 G catheter 2 0.00622 18.51 7.5000 7500 0.15$        
1 10cc syringe 1 0.01123 11.23 4.1700 4170 0.15$        
1 Y-type catheter 1 0.00868 8.68 0.1000 100.00 0.50$        
1 Tegaderm Dressing 1 0.00252 2.52 108.2000 108200 0.38$        
1 Saline, 500mL 1 0.48929 489.29 750.8390 750839.00 10.81$      
1 Iodine Pads 1 0.00108 1.08 0.1500 150.00 0.04$        
1 Alcohol Pads 12 0.00108 1.08 0.1500 150.00 0.02$        
1 Tourniquet 1 0.00603 6.03 5.0000 5000 0.24$        
1 Tape 0.1 0.00906 9.06 6.4220 6422.00 0.11$        
1 Morphine  1-10ml 0.00795 7.95 6.8855 6885.53  $     21.50 
1 carpuject 1 0.01524 15.24 5.6267 5626.67 5.01$        
Mass
Kg            Gm
Volume 
cc3          mm3
Best Case Scenario
Worst Case Scenario
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Resource Table Assumptions
• The Resource Tables reflect the current ISS 
medical equipment, supplies, drugs, etc.
• Conditions go “untreated” when an 
“essential” item is not available (due to 
depletion or omission from the health care 
system)
• Cost information only includes Commercial 
off-the-shelf (COTS)
• Spacecraft resources (e.g. oxygen, water, 
power, bandwidth) are not constrained
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In-flight Mitigation
• Resource Tables 
identify the resources 
required to mitigate 
risk by providing the 
in-flight capability to 
diagnose and treat 
medical conditions
• Medical resources 
can be optimized for 
specific mission and 
crew profiles
54321
Outcome
RiskRisk Risk Ri
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Summary of IMM Inputs
• Relevant list of medical conditions 
established 
• Incidence data established for each medical 
conditions 
• Crew functional impairments and end states 
(evacuation and loss of crew life) used to 
characterize impact due to medical events 
• Standardized tool (CliFF) established for 
clinical inputs of likelihood and outcomes for 
each medical condition
• Resource Tables specify essential and non-
essential resources required to diagnose and 
treat each medical condition
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IMM Outputs
“Essentially, all models are wrong, but some 
are useful.”
George Box (1987)
Professor Emeritus of Statistics at the 
University of Wisconsin
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Statistical Methods
• IMM uses Monte Carlo simulation
• SAS software
• Distribution of outcomes
• Probability distributions
• Beta, Beta-PERT, Poisson, Bernoulli, Binomial, 
Lognormal, Uniform, Discrete uniform
• Crew Health Index (CHI)
• Quality-adjusted mission time
37
Quality-Adjusted Mission Time
• Modification of quality-adjusted life 
years (QALY)
• Standard epidemiologic measure
• Single, weighted measure of the net 
change in quality time
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Example of QALY
• Consider the following individual:
• 35 years old
• 75-year life expectancy
• Medical event results in 30% functional impairment
• Below knee amputation
• What is the QALY?
• With respect to IMM, “Life” is mission time
%70%100
40
28
yrs 2812403.04040
PQALY
QALY
Crew Health 
Index (CHI)
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Crew Health Index (CHI)
Measure of crew health based on 
functional impairment
• Ranges from 0 to 100%
• 0% - completely impaired due to medical 
conditions for duration of mission
• 100% - no impairment due to medical 
conditions
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Key Model Assumptions
• 83 medical conditions
• ISS Health Maintenance System (HMS)
• Conservative estimate of Crew Health 
Index (CHI)
• Medical events assumed to occur on the 
first day of the mission
Case Study - Orion Medical Kit Design
• Goal
• Identify a medical kit that maximizes the CHI while 
meeting mass and volume constraints 
• Mass < 4.30 kg
• Volume < 6421.68 cm3
• Mission Scenario
• Crew of four
• 3-day Orion transfer mission
• Success Criterion
• The optimized medical kit approaches a risk profile 
of a medical kit with unlimited resources
Orion Medical Kit Design - Results
Attribute Constraint Optimized 
Kit
“Bottomless” 
Kit
Mass (kg) 4.30 4.24* 43.60
Volume (cm3) 6421.68 6421.68* 144684
CHI (95% C.I.) --- 84.34 (66-93) 84.55 (67-93)
Risk of EVAC --- 1.07% 0.07%
Risk of LOCL --- 0.02% 0.01%
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Mission Crew Health Index
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Crew Health Index (CHI)
Optimized Kit“Bottomless” Kit
*Includes 30% packing factor
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Orion Medical Kit Design - Conclusions
• A shoebox-sized kit can be designed
• Treats medical conditions with a high probability of 
occurrence during a 3-day mission 
• Does so without a reduction in CHI from the fully 
treated scenario.
• The Trade-off
• Does not include resources to treat low probability, 
worst-case scenario conditions
• Increases the probability of EAVC and LOCL 
respective to the fully treated scenario.
Validation – ISS EVAC Rates
Source Low 
(events/person-yr)
Max 
(events/person-yr)
IMM 0.018 0.027*
Terrestrial General Population 0.060 -
Antarctic Population 0.036 -
U.S. Submarine Population 0.023 0.028
Russian Historical Space Flight 
Data
0.032 0.072
LSAH Data 0.010 0.020
Space Station Freedom Clinical 
Experts Seminar Proceedings 
(1990)
0.010 0.030
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IMM forecasted EVAC rates compare favorably with 
literature review EVAC rates (0.010 to 0.072)
* Reference Mission 2: 6 crew, 6 month mission
Validation – ISS LOCL Rates
45
Source LOCL (events/person-yr)
IMM 
(3 crew/6-month mission)
0.0042
IMM 
(6 crew/6-month mission)
0.0043
Terrestrial Mortality Rate 0.0081 (2006)
48-year old male 0.0048 (2005)
48-year old female 0.0029 (2005)
Antarctic 0.0054 (1904-1964)
LSAH Data 0.0054 (1959-1991)
IMM forecasted LOCL rates compare favorably with 
literature review results for LOCL rates (0.0029 to 0.0081)
Validation - Sensitivity Analysis
IMM Simulation Data
Medical (59%)
1. Kidney Stone
2. Exposed Dental Pulp
3. Skin Infection
4. Urinary Tract Infection
5. Sepsis
6. Atrial fibrillation
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Injury (21%)
1. Chest Injury
2. Wrist Fracture
Environmental (20%)
1. Toxic Exposure
2. Smoke Inhalation
Actual Russian Flight Data
Three EVACs 
1. Urosepsis
2. Cardiac Arrhythmia
3. Toxic Exposure
Three Close Call EVACs
1. Kidney Stone
2. Dental Abscess
3. Toxic Exposure
NOTE:  No Russian input data is in IMM
Validation – ISS Total Medical Events
Mission # ISS  Medical 
Events 
(Observed)
IMM  Medical 
Events 
(Expected)
IMM 95% 
Confidence 
Interval
1 7 12 6 - 19
2 14 18 10 - 26
3 13 18 10 - 26
4 10 14 8 - 21
5 14 15 8 - 23
6 16 17 9 - 25
7 22 19 11 - 28
47
Validation – ISS Total Medical Events
48
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Capability Status
• IMM 2.1/3.0 
• Locked down and undergoing clinical validation
• Available for risk assessments, trade studies
• 83 medical conditions represented (47 of 83 
medical conditions have been recorded to 
occur in flight)
• In-flight medical resources identified per 
medical condition
• “Medical”, “injury”, or “environmental” 
classification of risk drivers
• Established database; build out continues
• Integrated citation management software
Next Steps through Sept 2010
• Validation of IMM 3.0 per plan (Jan-July)
• IMM Database 3.0 Development (Jan-July)
• Complete Ops Documentation (July)
• Operational Acceptance Review (Aug)
• Delivery of IMM 3.0 (Sept)
• Delivery of Database 3.0 (Sept)
• IMM 4.0 Development (Feb-Sept)
• Transition to Operations (1 October 2010)
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Summary
• IMM provides an evidence-based analysis of 
likely medical events and outcomes during 
space flight missions
• IMM provides the capability to assess risk
• IMM provides the capability to optimize 
medical systems
• IMM is a tool to assist in the decision making 
process
• It does not make decisions
52
Closing
* Source: NASA Return to Flight Task Group Final Report: Annex A.2 Individual Member 
Observations by Dr. Dan L. Crippen, Dr. Charles C. Daniel, Dr. Amy K. Donahue, Col. 
Susan J. Helms, Ms. Susan Morrisey Livingstone, Dr. Rosemary O'Leary, and Mr. William 
Wegner.
…experience and instinct are poor substitutes for 
careful analysis of uncertainty…
…This requires that analytical models be used 
appropriately to inform decisions…*
IMM addresses the observations documented by the RTF Task Group
53
Questions?
